SMTL ID : 5ia5.1

Crystal Structure of Ephrin A2 (EphA2) Receptor Protein Kinase with golvatinib (E7050)

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.78 Å

Oligo State

monomer

Ligands

1 x GV0: golvatinib(Non-covalent)

GV0.1: 23 residues within 4Å: Chain A: I.25, V.33, A.50, K.52, E.69, M.73, F.76, I.81, I.82, T.98, E.99, Y.100, M.101, E.102, G.104, E.112, L.136, Y.141, L.152, V.161, S.162, D.163, F.164 16 PLIP interactions: 16 interactions with chain A Hydrophobic interactions: A:A.50, A:K.52, A:E.69, A:I.81, A:I.82, A:T.98, A:Y.141, A:L.152, A:D.163 Hydrogen bonds: A:M.101, A:M.101, A:D.163 Water bridges: A:E.69, A:M.73 Salt bridges: A:E.112 pi-Stacking: A:F.164

3 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)

EDO.2: 1 residues within 4Å: Chain A: Q.22 No protein-ligand interaction detected (PLIP) EDO.3: 0 residues within 4Å: (No contacts) No protein-ligand interaction detected (PLIP) EDO.4: 5 residues within 4Å: Chain A: R.222, Y.224, W.225, E.226, P.243 3 PLIP interactions: 3 interactions with chain A Hydrogen bonds: A:R.222, A:Y.224, A:W.225

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Heinzlmeir, S. et al., Chemical Proteomics and Structural Biology Define EPHA2 Inhibition by Clinical Kinase Drugs. ACS Chem. Biol. (2016)

Release Date

2016-11-09

Peptides

Ephrin type-A receptor 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Ephrin type-A receptor 2

Related Entries With Identical Sequence